CACCURI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 7.039
AS - Asia 3.290
EU - Europa 2.609
SA - Sud America 677
AF - Africa 89
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.733
Nazione #
US - Stati Uniti d'America 6.916
SG - Singapore 1.234
CN - Cina 974
IT - Italia 642
BR - Brasile 561
HK - Hong Kong 425
UA - Ucraina 399
DE - Germania 304
PL - Polonia 267
VN - Vietnam 215
FI - Finlandia 208
FR - Francia 191
GB - Regno Unito 161
TR - Turchia 124
RU - Federazione Russa 119
IE - Irlanda 94
IN - India 82
CA - Canada 52
AR - Argentina 49
BD - Bangladesh 45
MX - Messico 42
SE - Svezia 42
IQ - Iraq 29
BE - Belgio 28
ID - Indonesia 28
ZA - Sudafrica 28
NL - Olanda 25
JP - Giappone 24
CZ - Repubblica Ceca 23
AT - Austria 22
AU - Australia 22
ES - Italia 22
UZ - Uzbekistan 17
EC - Ecuador 13
PK - Pakistan 13
VE - Venezuela 13
CO - Colombia 12
JO - Giordania 12
LT - Lituania 12
MA - Marocco 12
EG - Egitto 10
CR - Costa Rica 9
CL - Cile 8
KE - Kenya 8
AZ - Azerbaigian 7
ET - Etiopia 7
PT - Portogallo 7
EU - Europa 6
NO - Norvegia 6
PE - Perù 6
PY - Paraguay 6
SA - Arabia Saudita 6
UY - Uruguay 6
DZ - Algeria 5
IL - Israele 5
IR - Iran 5
JM - Giamaica 5
KG - Kirghizistan 5
LB - Libano 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
HR - Croazia 4
KZ - Kazakistan 4
LV - Lettonia 4
NG - Nigeria 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
KR - Corea 3
LK - Sri Lanka 3
MU - Mauritius 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
BY - Bielorussia 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
GT - Guatemala 2
KW - Kuwait 2
MD - Moldavia 2
MY - Malesia 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
TC - Turks e Caicos 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
HN - Honduras 1
HU - Ungheria 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 13.721
Città #
Fairfield 717
Ashburn 682
Singapore 666
Woodbridge 504
Hong Kong 424
San Jose 355
Seattle 352
Houston 317
Cambridge 299
Jacksonville 288
Ann Arbor 270
Warsaw 262
Chandler 255
Wilmington 240
Beijing 231
Dallas 228
Brescia 223
The Dalles 223
New York 193
Princeton 167
Helsinki 143
Los Angeles 140
Istanbul 102
Lauterbourg 98
Dublin 94
Ho Chi Minh City 78
Munich 78
Shanghai 71
Dearborn 62
Nanjing 61
São Paulo 57
Chicago 52
Redondo Beach 50
Des Moines 48
San Francisco 48
Orem 46
Hanoi 44
Buffalo 43
Council Bluffs 43
Moscow 36
San Diego 36
Milan 33
Santa Clara 33
Hebei 31
London 30
Turku 30
Nanchang 29
Changsha 28
Brussels 27
Boardman 26
Jinan 24
Nuremberg 24
Rome 23
Shenyang 22
Stockholm 22
Atlanta 21
Brooklyn 21
Tianjin 21
Brno 20
Johannesburg 20
Tokyo 20
Frankfurt am Main 19
Mexico City 18
Phoenix 18
Boston 17
Charlotte 17
Denver 17
Guangzhou 17
Manchester 17
Toronto 17
Montreal 16
Chennai 15
Jiaxing 15
Rio de Janeiro 15
Tashkent 15
Amsterdam 13
Belo Horizonte 13
Curitiba 12
Dong Ket 12
Kunming 11
Poplar 11
Romola 11
Salt Lake City 11
Baghdad 10
Porto Alegre 10
Taizhou 10
Zhengzhou 10
Amman 9
Kocaeli 9
Mumbai 9
Ningbo 9
San José 9
Verona 9
Buenos Aires 8
Falkenstein 8
Haikou 8
Kilburn 8
Lallio 8
Auburn Hills 7
Baku 7
Totale 9.306
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 341
Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy 257
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 216
A cluster of invasive listeriosis in Brescia, Italy. 216
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 213
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. 211
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 203
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 201
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 201
A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17 196
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. 183
In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae. 181
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. 181
Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing. 180
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 178
The immunomodulatory molecule pidotimod induces the expression of the nod-like receptor nlrp12 and attenuates tlr-induced inflammation. 176
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition 172
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 169
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 167
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 165
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). 164
Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis. 163
Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones 160
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 159
The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions 158
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 157
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 157
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 156
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 155
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 153
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 153
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 151
HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness 150
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 150
Extensively drug-resistant Acinetobacter baumannii isolated from intensive care units in Northern Italy: a genomic approach to characterize new sequence types. 149
Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia. 149
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. 147
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 147
Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy 145
Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients. 145
HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis. 145
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 144
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 142
HIV-1 matrix protein p17 and its receptors. 140
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 137
Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudine. 134
Multicenter Evaluation of the Anyplex™ Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-resistant Isolates in Pulmonary and Extrapulmonary Specimens 134
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 134
Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells 134
HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS. 133
Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case report 132
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 132
A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine 132
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient 130
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 126
Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae" 125
p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation 123
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 122
A topical desiccant agent in association with ultrasonic debridement in the initial treatment of chronic periodontitis: a clinical and microbiological study 121
Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants 121
Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G 117
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 116
Programmable Nucleic Acid Nanoswitches for the Rapid, Single-Step Detection of Antibodies in Bodily Fluids 115
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 115
HIV-1 infection, microenvironment and endothelial cell dysfunction. 114
Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120 114
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 112
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 111
The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy 109
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 108
In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma 107
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study 106
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 105
Role of Q675H mutation in improving SARS-CoV-2 spike interaction with the furin binding pocket 105
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 103
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 101
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 99
Genomic surveillance of SARS-CoV-2 in patients presenting neurological manifestations 94
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 94
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 91
Traceability of SARS-CoV-2 transmission through quasispecies analysis 91
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants 91
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants 89
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 87
THE ROLE OF GLYCOSAMINOGLYCANS IN SPIKE SARS-CoV-2 INFECTION: FROM A MODEL FOR HEPARAN SULFATES TO A STARTING STRUCTURE FOR ANTIVIRALS 86
The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier 85
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 84
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 84
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of sars-cov-2 infectivity 83
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 78
Clinical Performance of OncoPredict HPV Screening Assay on Self-Collected Vaginal and Urine Specimens Within the VALHUDES Framework 77
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 77
Detection of SARS-CoV-2 Alpha variant in a severely immunocompromised HIV-1-infected patient in the omicron era 75
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 74
The role of heparin in spike SARS-COV-2 infection: From a model for heparan sulfates to a starting structure for antivirals 72
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 72
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 71
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies 66
Viral proteins as emerging cancer therapeutics 63
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 59
Totale 13.416
Categoria #
all - tutte 66.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021408 0 0 0 0 0 0 0 0 0 192 147 69
2021/2022845 71 129 9 47 17 34 45 83 32 94 63 221
2022/2023839 121 11 28 54 77 199 4 107 142 2 52 42
2023/2024895 61 18 75 65 46 141 50 43 184 26 46 140
2024/20252.118 32 14 22 284 156 195 205 102 202 188 442 276
2025/20264.485 436 619 469 581 463 355 752 167 227 416 0 0
Totale 14.055